Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide.
Couture E, Bongard V, Maiza JC, Bennet A, Caron P. Couture E, et al. Among authors: maiza jc. Pituitary. 2012 Dec;15(4):518-25. doi: 10.1007/s11102-011-0361-9. Pituitary. 2012. PMID: 22058008
Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa.
Maiza JC, Vezzosi D, Matta M, Donadille F, Loubes-Lacroix F, Cournot M, Bennet A, Caron P. Maiza JC, et al. Clin Endocrinol (Oxf). 2007 Aug;67(2):282-9. doi: 10.1111/j.1365-2265.2007.02878.x. Epub 2007 May 24. Clin Endocrinol (Oxf). 2007. PMID: 17524029 Free PMC article. Clinical Trial.
Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotide.
Maiza JC, Castillo-Ros S, Matta M, Bennet A, Caron P. Maiza JC, et al. Pituitary. 2012 Dec;15 Suppl 1:S23-7. doi: 10.1007/s11102-010-0287-7. Pituitary. 2012. PMID: 21221819
Clinical and metabolic characteristics of acromegalic patients with high IGF1/normal GH levels during somatostatin analog treatment.
Matta M, Bongard V, Grunenwald S, Maiza JC, Bennet A, Caron P. Matta M, et al. Among authors: maiza jc. Eur J Endocrinol. 2011 Jun;164(6):885-9. doi: 10.1530/EJE-11-0098. Epub 2011 Apr 6. Eur J Endocrinol. 2011. PMID: 21471168
Acromegaly revealed by 18FDG-PET/CT in a plasmocytoma patient.
Maiza JC, Zunic P, Revel C, Schneebeli S. Maiza JC, et al. Pituitary. 2012 Dec;15(4):614-5. doi: 10.1007/s11102-012-0438-0. Pituitary. 2012. PMID: 23080123 No abstract available.
Increased plasma β-hydroxybutyrate levels during the fasting test in patients with endogenous hyperinsulinaemic hypoglycaemia.
Buffet A, Vezzosi D, Maiza JC, Grunenwald S, Bennet A, Caron P. Buffet A, et al. Among authors: maiza jc. Eur J Endocrinol. 2013 Jun 7;169(1):91-7. doi: 10.1530/EJE-13-0020. Print 2013 Jul. Eur J Endocrinol. 2013. PMID: 23657581
Evolution of (18)FDG pituitary uptake after medical control of acromegaly.
Maiza JC, Revel C. Maiza JC, et al. Pituitary. 2014 Jun;17(3):296-7. doi: 10.1007/s11102-013-0513-1. Pituitary. 2014. PMID: 23982451 No abstract available.
High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
Caron P, Maiza JC, Renaud C, Cormier C, Barres BH, Souberbielle JC. Caron P, et al. Among authors: maiza jc. Clin Endocrinol (Oxf). 2009 Apr;70(4):533-8. doi: 10.1111/j.1365-2265.2008.03408.x. Clin Endocrinol (Oxf). 2009. PMID: 18782355
Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation.
Caron P, Simonds WF, Maiza JC, Rubin M, Cantor T, Rousseau L, Bilezikian JP, Souberbielle JC, D'Amour P. Caron P, et al. Among authors: maiza jc. Clin Endocrinol (Oxf). 2011 Jun;74(6):694-8. doi: 10.1111/j.1365-2265.2011.04021.x. Clin Endocrinol (Oxf). 2011. PMID: 21521290 Free PMC article.
Are basal and glucagon-stimulated C-peptide values predictors of response to GLP-1 receptor agonists in type 2 diabetic patients?
Maiza JC, Gérard P, Rollot O, Cogne M, Jarlet E, Schneebeli S. Maiza JC, et al. Minerva Endocrinol. 2016 Mar;41(1):138-40. Minerva Endocrinol. 2016. PMID: 26878563 No abstract available.
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback